341 related articles for article (PubMed ID: 36432531)
21. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
22. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
[TBL] [Abstract][Full Text] [Related]
23. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
24. Qinghua Fang inhibits high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota.
Wang Y; Lv S; Shen T; Ye M; Wang D; Zhou P; Li Y; Zhang W
Ann Palliat Med; 2021 Mar; 10(3):3219-3234. PubMed ID: 33849107
[TBL] [Abstract][Full Text] [Related]
25. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
26. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.
Huang SW; Ou YC; Tang KS; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Hou CY; Tsai CC; Tiao MM
Lipids Health Dis; 2021 Sep; 20(1):100. PubMed ID: 34496884
[TBL] [Abstract][Full Text] [Related]
27. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice.
Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z
Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440
[TBL] [Abstract][Full Text] [Related]
28. Preventive mechanisms of Chinese Tibetan medicine Triphala against nonalcoholic fatty liver disease.
Jiang Y; Zhao L; Ma J; Yang Y; Zhang B; Xu J; Dhondrup R; Wong TW; Zhang D
Phytomedicine; 2024 Jan; 123():155229. PubMed ID: 38006804
[TBL] [Abstract][Full Text] [Related]
29. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
Sun J; Fan J; Li T; Yan X; Jiang Y
J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
[TBL] [Abstract][Full Text] [Related]
30. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.
Mu J; Cheng F; Wang Q; Wang X; Zhu W; Ma C; Yin X; Ren B; Lian Y; Du X; Zhang H; Liu S; Zhang S
J Tradit Chin Med; 2020 Apr; 40(2):253-266. PubMed ID: 32242391
[TBL] [Abstract][Full Text] [Related]
31. Walnut green husk ethanol extract improves gut microbiota and their metabolites associated with NLRP3 in non-alcoholic steatohepatitis.
Fang Q; Li X; Wang M; Qiao X; Huang F; Hu C; Xue Y; Zhao S; Lin Y
Food Funct; 2022 Jun; 13(11):6387-6403. PubMed ID: 35616069
[TBL] [Abstract][Full Text] [Related]
32. The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids.
Xia F; Xiang S; Chen Z; Song L; Li Y; Liao Z; Ge B; Zhou B
Arch Biochem Biophys; 2021 Dec; 714():109080. PubMed ID: 34742934
[TBL] [Abstract][Full Text] [Related]
33. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2.
Shatoor AS; Al Humayed S; Almohiy HM
J Physiol Biochem; 2022 Feb; 78(1):151-168. PubMed ID: 34651285
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
35. [Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice].
Yao FF; Zheng PY; Huang H; Bai LM; Ding YR; Mei L; Liu SM
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):927-933. PubMed ID: 29325294
[No Abstract] [Full Text] [Related]
36. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C
Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
[TBL] [Abstract][Full Text] [Related]
37. Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway.
Liu YL; Zhang QZ; Wang YR; Fu LN; Han JS; Zhang J; Wang BM
Front Pharmacol; 2020; 11():605064. PubMed ID: 33708118
[No Abstract] [Full Text] [Related]
38. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
39. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
40. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
